Invokana graphic

The Food and Drug Administration just issued another Drug Safety Communication alerting doctors and patients about serious health risks associated with several type 2 diabetes medications, including Invokana. The FDA is strengthening warnings about the risk of serious, acute kidney injuries for patients taking type 2 diabetes medications canagliflozin (Invokana, Invokamet) and dapagliflozin (Farxiga, Xigduo…

Read More